Biologics Spine Innovative Spinal Biomaterial Demonstrates Early Healing in Retrospective Study byChris StewartSeptember 8, 2022
Recon After 30 Years, the Company Responsible for Improving Millions of Titanium Implants Finally Has Something to Say byChris StewartJune 25, 2021
Biologics Spine Top Stories New Injection Repair Strategy Can Prevent Risk of Re-herniation, Reduce Disability and Pain byJosh SandbergNovember 11, 2020
Hospitals Graftys granted key U.S. patent for GRFT-R02, a highly osteogenic biomaterial byJosh SandbergJuly 11, 2016
Biologics Financial Amedica Corporation Amends Series A and C Warrants byJosh SandbergDecember 15, 2015
Biologics Spine InVivo Therapeutics Announces Jay Blackington as New Vice President, Head of Human Resources byJosh SandbergNovember 25, 2015
Hospitals Amedica Submits 24-Month Clinical Data to FDA for Clearance of Composite Interbody Spinal Device byJosh SandbergNovember 11, 2015
Spine Amedica Launches Innovative Articulating Inserter for Minimally Invasive TLIF Procedures byJosh SandbergOctober 14, 2015
Biologics Amedica Breaks into the Dental Market with Recent Joint Development Agreement byJosh SandbergOctober 12, 2015
Biologics Recon Kuros to Present at the 2015 Orthopedic Trauma Association Annual Meeting byJosh SandbergOctober 5, 2015